Celegence CEO Sonia Veluchamy Featured in MedTech Strategist
Our CEO Sonia A. Veluchamy recently contributed to the October 2024 issue of MedTech Strategist. In the article she shared her insights on new data usage techniques and highlighted the latest research among medtech company RA professionals to optimize compliance plans.
Article Highlights
- Celegence and industry partners conducted research which shows that 77% of regulatory affairs teams in medical device teams are under-resourced
- Organization and structuring of product data can provide significant efficiencies by reducing number of documents and improving workflows
- Technology combined with expertise can be critical in helping teams manage the growing demands and workloads in Regulatory Affairs such as GenAI and structured data
Read the full article in Market Pathways.
Celegence’s Expertise
Celegence has proven experience with medical writing for regulatory submissions. Our deep regulatory expertise, combined with advanced AI-Enabled technology solutions, positions us uniquely to handle the complexities of medical writing. We ensure that every document is not only compliant but crafted to expedite approval processes and facilitate market access. For more information about our services can benefit your regulatory processes, contact us today.
